Observational study on clinical outcome prediction of anti-epidermal growth factor receptor for colorectal cancer based on DNA methylation status and gene expression status.

Observational study on clinical outcome prediction of anti-epidermal growth factor receptor for colorectal cancer based on DNA methylation status and gene expression status. - Observational study on clinical outcome prediction of anti-epidermal growth factor receptor for colorectal cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027296

Enrollment

150

Registered

2017-05-11

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: This study designed for KRAS wild-type metastatic colorectal cancer patients who received anti-EGFR treatment.

Exclusion criteria

Exclusion criteria: Cases with mutations in KRAS are excluded from the subject.

Design outcomes

Primary

Measure	Time frame
PFS (Progression Free Survival) / RR (Response Rate)	—

Secondary

Measure	Time frame
OS (Overall Survival)	—

Countries

Japan

Contacts

Public ContactKota Ouchi

Institute of Development, Aging and Cancer (IDAC) Department of Clinical Oncology

kota.ouchi.b3@tohoku.ac.jp+81-22-717-8543

Outcome results